Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc N.MEDV


Primary Symbol: MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by GeneralWolfeon Aug 18, 2022 11:14am
234 Views
Post# 34904806

More good news...$$$

More good news...$$$Thanks for the cheap ones...Q2 2022 Financial Highlights
  • An increase of 72%, revenue was $25,776,974 in the six months ended June 30, 2022, compared to $14,990,373 over the prior six months ended June 30, 2021.
  • An increase of 483%, gross profit was $10,542,208 in the six months ended June 30, 2022, compared to $1,807,423 over the prior six months ended June 30, 2021.
  • An improvement of 60%, net loss was $7,414,236 in the six months ended June 30, 2022, compared to $18,675,021 over the prior six months ended June 30, 2021.
  • An increase of 5,056%, cash on hand was $5,794,883 as at June 30, 2022, compared to $112,397 as at December 31, 2021.
  • Cash provided by operating activities was $6,506,790 in the six months ended June 30, 2022, compared to cash used by operating activities of $13,020,254 in the prior six months ended June 30, 2021.
<< Previous
Bullboard Posts
Next >>